Tim Johnson - 20 Dec 2024 Form 3 Insider Report for Health In Tech, Inc. (HIT)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Tim Johnson
Issuer symbol
HIT
Transactions as of
20 Dec 2024
Transactions value $
$0
Form type
3
Filing time
20 Dec 2024, 21:00:14 UTC
Next filing
19 Aug 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding HIT Class A Common Stock 22,200,000 20 Dec 2024 Direct
holding HIT Class A Common Stock 96,856 20 Dec 2024 Direct F1
holding HIT Class A Common Stock 82,500 20 Dec 2024 Direct F2
holding HIT Class A Common Stock 56,385 20 Dec 2024 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HIT Class B Common Stock 20 Dec 2024 Class A Common Stock 9,000,000 Direct F4
holding HIT Stock Options 20 Dec 2024 Class A Common Stock 495,000 $0.7100 Direct F5
holding HIT Stock Options 20 Dec 2024 Class A Common Stock 170,115 $0.7100 Direct F6
holding HIT Stock Options 20 Dec 2024 Class A Common Stock 69,592 $0.7100 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represent restricted shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan, which vest upon the closing of the issuer's initial public offering, subject to the reporting person's continued service with the issuer through such vesting date.
F2 Represent restricted shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan, which vest six months after the closing of the issuer's initial public offering, subject to the reporting person's continued service with the issuer through such vesting date.
F3 Represent restricted shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan. The Restricted Stock vest over three years, with one-third of the Restricted Stock vesting upon the closing of the issuer's initial public offering and the remaining two-thirds vesting in equal quarterly installments over the remaining two years, subject to the reporting person's continued service with the issuer through each vesting date.
F4 Each share of Class B Common Stock is entitled to ten votes and is convertible at any time into one share of Class A Common Stock for no additional consideration.
F5 Represent options to purchase shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan. The stock options vest six months after the issuer's initial public offering, subject to the reporting person's continued service with the issuer through such vesting date.
F6 Represent options to purchase shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan. The stock options vest over three years, with one-third of the options vesting upon the issuer's initial public offering and the remaining two-thirds vesting in equal quarterly installments over the remaining two years, subject to the reporting person's continued service with the issuer through each vesting date.
F7 Represent options to purchase shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan. The stock options vest upon the closing of the issuer's initial public offering, subject to the reporting person's continued service with the issuer through such vesting date.